Literature DB >> 24728601

[Pharmacogenic osteoporosis beyond cortisone. Proton pump inhibitors, glitazones and diuretics].

P H Kann1, P Hadji, R S Bergmann.   

Abstract

BACKGROUND: [corrected] There are many drugs which can cause osteoporosis or at least favor its initiation. The effect of hormones and drugs with antihormonal activity, such as glucocorticoids and aromatase inhibitors, on initiation of osteoporosis is well known. In addition, proton pump inhibitors, glitazones and diuretics also influence the formation of osteoporosis.
MATERIAL AND METHODS: The results of currently available studies on the correlation between proton pump inhibitors, glitazones and diuretics on formation of osteoporosis were evaluated and summarized.
RESULTS: Proton pump inhibitors and glitazones increase the risk for osteoporotic fractures. Loop diuretics may slightly increase fracture risk, whereas thiazides were shown to be osteoprotective by reducing fracture probability on a relevant scale.
CONCLUSION: Proton pump inhibitors should not be prescribed without serious consideration and then only as long as necessary. Alternatively, the administration of the less effective H2 antagonists should be considered when possible due to the reduction of acid secretion. Because the long-term intake of thiazides is associated with a clinically relevant reduction in the risk of fractures and they are economic and well-tolerated, prescription can be thoroughly recommended within the framework of differential diagnostic considerations in an appropriate clinical context. The briefly increased risk of falling immediately after starting diuretic therapy is the only point which needs to be considered.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24728601     DOI: 10.1007/s00393-013-1286-7

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  41 in total

1.  Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative.

Authors:  Shelly L Gray; Andrea Z LaCroix; Joseph Larson; John Robbins; Jane A Cauley; JoAnn E Manson; Zhao Chen
Journal:  Arch Intern Med       Date:  2010-05-10

2.  A prospective study of thiazide use and fractures in women.

Authors:  D Feskanich; W C Willett; M J Stampfer; G A Colditz
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

3.  Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study.

Authors:  M R Langenfeld; T Forst; C Hohberg; P Kann; G Lübben; T Konrad; S D Füllert; C Sachara; A Pfützner
Journal:  Circulation       Date:  2005-05-09       Impact factor: 29.690

4.  Fracture risk in patients treated with loop diuretics.

Authors:  L Rejnmark; P Vestergaard; L Mosekilde
Journal:  J Intern Med       Date:  2006-01       Impact factor: 8.989

5.  Vertebral fracture efficacy during risedronate therapy in patients using proton pump inhibitors.

Authors:  C Roux; J L Goldstein; X Zhou; A Klemes; R Lindsay
Journal:  Osteoporos Int       Date:  2011-03-02       Impact factor: 4.507

6.  Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study.

Authors:  S Gonnelli; C Caffarelli; S Maggi; G Guglielmi; P Siviero; S Rossi; G Crepaldi; R Nuti
Journal:  Calcif Tissue Int       Date:  2010-06-22       Impact factor: 4.333

7.  Effects of thiazide diuretic therapy on bone mass, fractures, and falls. The Study of Osteoporotic Fractures Research Group.

Authors:  J A Cauley; S R Cummings; D G Seeley; D Black; W Browner; L H Kuller; M C Nevitt
Journal:  Ann Intern Med       Date:  1993-05-01       Impact factor: 25.391

Review 8.  Glargine safety, diabetes and cancer.

Authors:  Marc Rendell; Halis Kaan Akturk; Sri Harsha Tella
Journal:  Expert Opin Drug Saf       Date:  2013-02-11       Impact factor: 4.250

9.  Fine-Tuning Reception in the Bone: PPARgamma and Company.

Authors:  Z Elizabeth Floyd; Sanjin Zvonic; Mark E Nuttall; Jeffrey M Gimble
Journal:  PPAR Res       Date:  2006       Impact factor: 4.964

10.  Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone.

Authors:  Melita M Dvorak; Cyrille De Joussineau; D Howard Carter; Trairak Pisitkun; Mark A Knepper; Gerardo Gamba; Paul J Kemp; Daniela Riccardi
Journal:  J Am Soc Nephrol       Date:  2007-07-26       Impact factor: 10.121

View more
  3 in total

1.  Commonly Prescribed and Over-the-Counter Drugs as Secondary Causes of Osteoporosis-Part Two.

Authors:  Joseph Pizzorno; Lara Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2021-06

2.  Thiazide use and skeletal microstructure: Results from a multi-ethnic study.

Authors:  Hoang-Long Huynh; Lena Fan; Carmen Germosen; Mariana Bucovsky; Ivelisse Colon; Nayoung Kil; Sanchita Agarwal; Marcella Walker
Journal:  Bone Rep       Date:  2022-05-10

3.  High incidence of fracture events in patients with Long-Gap Esophageal Atresia (LGEA): A retrospective review prompting implementation of standardized protocol.

Authors:  Sigrid Bairdain; Brenda Dodson; David Zurakowski; Lawrence Rhein; Brian D Snyder; Melissa Putman; Russell W Jennings
Journal:  Bone Rep       Date:  2015-06-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.